Company Filing History:
Years Active: 2019-2021
Title: Moon Young Park: Innovator in Therapeutics
Introduction
Moon Young Park is a prominent inventor based in Gwangju, South Korea. He has made significant contributions to the field of therapeutics, particularly in the development of innovative treatments for diabetes and breast cancer. With a total of 2 patents, his work showcases a commitment to advancing medical science.
Latest Patents
Among his latest patents is an exenatide analogue, which represents a novel approach to diabetes treatment. This invention involves a modified exenatide where the first to fifteenth amino acids from the C-terminal of the amino acid sequence are deleted, and a fatty acid is conjugated. The result is a shorter exenatide that exhibits comparable anti-diabetic effects to conventional exenatide and liraglutide, while also reducing preparation costs. Another significant patent is a breast cancer therapeutic agent that contains 5'-hydroxy-5-nitro-indirubin-3'-oxime as the active ingredient. This agent is particularly relevant for treating triple-negative breast cancer (TNBC) and estrogen receptor (ER) positive breast cancer, including tamoxifen-resistant cases.
Career Highlights
Moon Young Park is associated with Anygen Co., Ltd., where he continues to contribute to innovative research and development. His work has positioned him as a key figure in the therapeutic landscape, particularly in addressing critical health challenges.
Collaborations
He collaborates with notable colleagues, including San Ho Kim and Seon Myung Kim, who share his vision for advancing medical treatments.
Conclusion
Moon Young Park's contributions to the field of therapeutics through his innovative patents highlight his role as a leading inventor. His work not only addresses pressing health issues but also paves the way for future advancements in medical science.